Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus.

Yu F, Harada JN, Brown HJ, Deng H, Song MJ, Wu TT, Kato-Stankiewicz J, Nelson CG, Vieira J, Tamanoi F, Chanda SK, Sun R.

PLoS Pathog. 2007 Mar;3(3):e44.

2.

Targeting the PI3K and MAPK pathways to treat Kaposi's-sarcoma-associated herpes virus infection and pathogenesis.

Lambert PJ, Shahrier AZ, Whitman AG, Dyson OF, Reber AJ, McCubrey JA, Akula SM.

Expert Opin Ther Targets. 2007 May;11(5):589-99. Review.

PMID:
17465719
3.

Signaling through RAS-RAF-MEK-ERK: from basics to bedside.

Zebisch A, Czernilofsky AP, Keri G, Smigelskaite J, Sill H, Troppmair J.

Curr Med Chem. 2007;14(5):601-23. Review.

PMID:
17346150
4.

Gamma-herpesviruses and cellular signaling in AIDS-associated malignancies.

Noguchi K, Fukazawa H, Murakami Y, Takahashi N, Yamagoe S, Uehara Y.

Cancer Sci. 2007 Sep;98(9):1288-96. Epub 2007 Jul 19. Review.

5.

Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.

Viejo-Borbolla A, Schulz TF.

AIDS Rev. 2003 Oct-Dec;5(4):222-9. Review.

PMID:
15012001
6.

Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Paul AG, Chandran B, Sharma-Walia N.

Transl Res. 2013 Aug;162(2):77-92. doi: 10.1016/j.trsl.2013.03.004. Epub 2013 Apr 6. Review.

PMID:
23567332
7.

Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy.

Andrei G, Snoeck R.

Curr Opin Infect Dis. 2015 Dec;28(6):611-24. doi: 10.1097/QCO.0000000000000213. Review.

PMID:
26524334

Supplemental Content

Support Center